Sox6 has been implicated in diabetic nephropathy (Jiang et al., 2020; Qi et al., 2019), adipogenesis (Leow et al., 2016), cardiomyopathy (Yousefzadeh et al., 2017), inflammatory bowel disease (Kinchen et al., 2018), and cancer (Liang et al., 2019). Here, SOX6 is linked to cancer.